Literature DB >> 24481971

Plaque inflammation and unstable morphology are associated with early stroke recurrence in symptomatic carotid stenosis.

Michael Marnane1, Susan Prendeville, Ciaran McDonnell, Imelda Noone, Mary Barry, Morgan Crowe, Niall Mulligan, Peter J Kelly.   

Abstract

BACKGROUND AND
PURPOSE: Although symptomatic carotid stenosis is associated with 3-fold increased risk of early stroke recurrence, the pathophysiologic mechanisms of high early stroke risk have not been established. We aimed to investigate the relationship between early stroke recurrence after initial symptoms and histological features of plaque inflammation and instability in resected carotid plaque.
METHODS: Carotid endarterectomy tissue from consecutive patients with ipsilateral stenosis≥50% and recent symptoms were analyzed using a validated histopathologic algorithm (Oxford Plaque Study [OPS] system). Nonprocedural stroke recurrence before carotid endarterectomy was ascertained at 7, 28, and 90 days after initial symptoms.
RESULTS: Among 44 patients meeting eligibility criteria, 27.3% (12/44) had stroke recurrence after initial stroke/transient ischemic attack but before carotid endarterectomy. Compared with patients without recurrence, stroke recurrence was associated with dense macrophage infiltration (OPS grade≥3; 91.7% versus 37.5%; P=0.002), extensive (>25%) fibrous cap disruption (90.9% versus 37%; P=0.004), neovascularization (OPS grade≥2; 83.3% versus 43.8%; P=0.04), and low plaque fibrous content (OPS grade<2; 50% versus 6.3%; P=0.003). Early recurrence rates were 82.3% (confidence interval, 49.2%-98.8%) in patients with extensive plaque macrophage infiltration (OPS grade≥3) compared with 22.2% (confidence interval, 3.5%-83.4%) in those with OPS grade<3 (log-rank P=0.009). On multivariable Cox regression, including OPS macrophage grade (≥3 or <3), age, and severity of stenosis (50%-69% or ≥70%), plaque inflammation was the only variable independently predicting stroke recurrence (adjusted hazard ratio, 9; confidence interval, 1.1-70.6; P=0.04).
CONCLUSIONS: Plaque inflammation and other vulnerability features were associated with highest risk of stroke recurrence and may represent therapeutic targets for future stroke prevention trials.

Entities:  

Keywords:  atherosclerosis; carotid stenosis; inflammation; pathology; stroke

Mesh:

Substances:

Year:  2014        PMID: 24481971     DOI: 10.1161/STROKEAHA.113.003657

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

1.  High-risk plaque features can be detected in non-stenotic carotid plaques of patients with ischaemic stroke classified as cryptogenic using combined (18)F-FDG PET/MR imaging.

Authors:  Fabien Hyafil; Andreas Schindler; Dominik Sepp; Tilman Obenhuber; Anna Bayer-Karpinska; Tobias Boeckh-Behrens; Sabine Höhn; Marcus Hacker; Stephan G Nekolla; Axel Rominger; Martin Dichgans; Markus Schwaiger; Tobias Saam; Holger Poppert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-03       Impact factor: 9.236

2.  A novel atherothrombotic model of ischemic stroke induced by injection of collagen into the cerebral vasculature.

Authors:  Kathryn J Schunke; Thomas K Toung; Jian Zhang; Arvind P Pathak; Jiadi Xu; Jiangyang Zhang; Raymond C Koehler; Nauder Faraday
Journal:  J Neurosci Methods       Date:  2014-10-12       Impact factor: 2.390

3.  Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.

Authors:  Xiao-Wu Hong; Dong-Mei Wu; Jun Lu; Yuan-Lin Zheng; Wen-Jun Tu; Jing Yan
Journal:  Mol Neurobiol       Date:  2016-12-21       Impact factor: 5.590

4.  Histopathologic Validation of Grayscale Carotid Plaque Characteristics Related to Plaque Vulnerability.

Authors:  Carol C Mitchell; James H Stein; Thomas D Cook; Shahriar Salamat; Xiao Wang; Tomy Varghese; Daren C Jackson; Carolina Sandoval Garcia; Stephanie M Wilbrand; Robert J Dempsey
Journal:  Ultrasound Med Biol       Date:  2016-10-05       Impact factor: 2.998

5.  Perivascular Fat Density and Contrast Plaque Enhancement: Does a Correlation Exist?

Authors:  L Saba; S Zucca; A Gupta; G Micheletti; J S Suri; A Balestrieri; M Porcu; P Crivelli; G Lanzino; Y Qi; V Nardi; G Faa; R Montisci
Journal:  AJNR Am J Neuroradiol       Date:  2020-07-30       Impact factor: 3.825

6.  Attenuation Coefficient Parameter Computations for Tissue Composition Assessment of Carotid Atherosclerotic Plaque in Vivo.

Authors:  Catherine N Steffel; Shahriar Salamat; Thomas D Cook; Stephanie M Wilbrand; Robert J Dempsey; Carol C Mitchell; Tomy Varghese
Journal:  Ultrasound Med Biol       Date:  2020-04-11       Impact factor: 2.998

Review 7.  Immune interventions in stroke.

Authors:  Ying Fu; Qiang Liu; Josef Anrather; Fu-Dong Shi
Journal:  Nat Rev Neurol       Date:  2015-08-25       Impact factor: 42.937

8.  [Treatment reality of internal carotid artery stenosis in Germany : requirement and reality in international comparison and in light of the current S3 guidelines].

Authors:  J Eyding; M Kitzrow; C Krogias; G Reimann; R Weber; C Weimar; D Bartig
Journal:  Nervenarzt       Date:  2015-10       Impact factor: 1.214

Review 9.  Oxidative Stress and Inflammation, Key Targets of Atherosclerotic Plaque Progression and Vulnerability: Potential Impact of Physical Activity.

Authors:  Pauline Mury; Erica N Chirico; Mathilde Mura; Antoine Millon; Emmanuelle Canet-Soulas; Vincent Pialoux
Journal:  Sports Med       Date:  2018-12       Impact factor: 11.136

10.  Interleukin-6, C-reactive protein, fibrinogen, and risk of recurrence after ischaemic stroke: Systematic review and meta-analysis.

Authors:  J J McCabe; E O'Reilly; S Coveney; R Collins; L Healy; J McManus; R Mulcahy; B Moynihan; T Cassidy; F Hsu; B Worrall; S Murphy; M O'Donnell; P J Kelly
Journal:  Eur Stroke J       Date:  2021-01-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.